LIR Life Sciences Announces Appointment of Dr. Peter Singer as Scientific Advisor

About this update from Lir Life Sciences Corp.

VANCOUVER, BC / ACCESS Newswire / December 18, 2025 / LIR Life Sciences Corp. (CSE:SKNY)(Frankfurt:N790, WKN: A41QA9) ("LIR" or the "Company") is pleased to announce that Dr. Peter Singer, a global health expert and former Special Advisor to the Director General of the World Health Organization (WHO), has joined the Company as a Scientific Advisor. Dr. Singer brings over 25 years of leadership in health innovation, public health policy, and global development. At WHO, he played a key role in developing the organization's global strategy and "triple billion" targets, supporting implementation across programs and member states. His work focused on measurable country-level impact, coordination among multilateral health agencies, and aligning health investments with sustainable development goals. [1] Prior to his tenure at WHO, Dr. Singer served as Chief Executive Officer of Grand Challenges Canada, where he oversaw over CAD $450 million in funding to support more than 1,000 health innovations across 90+ countries. These initiatives were designed to address global health challenges with measurable, cost-effective solutions. His academic background includes appointments as Professor of Medicine Emeritus at the University of Toronto and formerly Director of the Joint Centre for Bioethics, with research spanning medical ethics, health systems, and innovation policy. [2] Dr. Singer has received several national and international honors, including the Michael Smith Prize as Canada's Health Researcher of the Year in Population Health and Health Services, and appointment as an Officer of the Order of Canada for his contributions to global health and bioethics. He is a Fellow of the Royal Society of Canada, the Canadian Academy of Health Sciences, the U.S. National Academy of Medicine, and The World Academy of Sciences. [3] As Scientific Advisor, Dr. Singer will contribute to LIR's strategy for expanding access to affordable obesity treatments globally. His expertise in health system innovation and equity-focused policy will support the Company's mission to address the rising global burden of obesity with practical, scalable solutions. "Dr. Singer's track record in advancing global health innovation speaks for itself. His experience leading international health initiatives and shaping health policy at the highest...

View stock analysis, news, and events for Lir Life Sciences Corp.